SCHEMBL1011391

SCHEMBL1011391

COc1ccc(N(CCc2ccccc2)Cc2c(Cl)cncc2Cl)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
PDE4D Q08499 8/20 0.43
PDE4A P27815 4/20 0.43
PDE4B Q07343 4/20 0.43
PDE4C Q08493 4/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
BLM P54132 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HTR2A P28223 3/20 0.39
HTR2C P28335 3/20 0.39
HTR2B P41595 3/20 0.39
ADRB1 P08588 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1009113 0.90 PDE4D (0.45) L3MBTL1PDE4DPDE4APDE4BPDE4C
SCHEMBL1008443 0.82 PDE4D (0.47) PDE4DMEN1KMT2AKDM4ECYP1A2
SCHEMBL1010002 0.82 QPCT (0.49) PDE4DPDE4APDE4BPDE4CMEN1
SCHEMBL1008748 0.80 PDE4D (0.45) L3MBTL1PDE4DMEN1KMT2AKDM4E
SCHEMBL1010197 0.80 PDE4D (0.44) PDE4DPDE4APDE4BPDE4C
SCHEMBL1008845 0.79 PDE4D (0.44) L3MBTL1PDE4DPDE4BMEN1KMT2A
SCHEMBL3452400 0.79 PDE4D (0.45) PDE4DMEN1KMT2AKDM4EALDH1A1
SCHEMBL1008929 0.78 PDE4D (0.44) PDE4DMEN1KMT2AKDM4EALDH1A1
SCHEMBL1010015 0.78 CCR5 (0.45) PDE4D
SCHEMBL1011460 0.77 PDE4D (0.54) PDE4DMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268632-B1 TERTIARY AMINE DERIVATIVES AS PHOSPHODIESTERASE-4 INHIBITORS CHIESI FARMA SPA (IT) 2012-08-08 EP claimed
EP-2268632-A1 TERTIARY AMINE DERIVATIVES AS PHOSPHODIESTERASE-4 INHIBITORS CHIESI FARMACEUTICI S.p.A. (IT) 2011-01-05 EP claimed
US-7820698-B2 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class CHIESI FARMACEUTICI S.P.A. (IT) 2010-10-26 US claimed
WO-2009127320-A1 TERTIARY AMINE DERIVATIVES AS PHOSPHODIESTERASE-4 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2009-10-22 WO claimed
EP-2110375-A1 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class CHIESI FARMACEUTICI S.p.A. (IT) 2009-10-21 EP claimed
US-20090258905-A1 PHOSPHODIESTERASE-4 INHIBITORS BELONGING TO THE TERTIARY AMINE CLASS CHIESI FARMACEUTICI S.P.A. (IT) 2009-10-15 US claimed
EP-2268632-B1 TERTIARY AMINE DERIVATIVES AS PHOSPHODIESTERASE-4 INHIBITORS CHIESI FARMA SPA (IT) 2012-08-08 EP disclosed
EP-2110375-A1 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class CHIESI FARMACEUTICI S.p.A. (IT) 2009-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258905-A1 PHOSPHODIESTERASE-4 INHIBITORS BELONGING TO THE TERTIARY AMINE CLASS PDE4A, PDE4B, PDE2A L3MBTL1 3290/4885PDE4D 9/4885PDE4A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.